Related references
Note: Only part of the references are listed.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Theresa A. McDonagh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
Christoffer Nyborg et al.
SPORTS (2021)
Arginine and Endothelial Function
Jessica Gambardella et al.
BIOMEDICINES (2020)
Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients
Ines Potocnjak et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity
Lee-Hwa Tai et al.
ONCOIMMUNOLOGY (2018)
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study
Janine Wirth et al.
AMINO ACIDS (2017)
Detrimental effects of a bout of physical exercise on circulating endogenous inhibitors of endothelial function in patients with coronary artery disease
Marina Deljanin Ilic et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2017)
Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB)
Temdara Tun et al.
MICROVASCULAR RESEARCH (2017)
Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
Julie Lorin et al.
PLOS ONE (2017)
Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies
Sabrina Schlesinger et al.
PLOS ONE (2016)
Diminished Global Arginine Bioavailability as a Metabolic Defect in Chronic Systolic Heart Failure
W. H. Wilson Tang et al.
JOURNAL OF CARDIAC FAILURE (2013)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
The L-Arginine-Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy
Maike Anderssohn et al.
JOURNAL OF CARDIAC FAILURE (2012)
Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cells
Hongmei Cui et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
The L-Arginine-Asymmetric Dimethylarginine Ratio Is Strongly Related to the Severity of Chronic Heart Failure. No Effects of Exercise Training
Ingebjorg Seljeflot et al.
JOURNAL OF CARDIAC FAILURE (2011)
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature
Marlieke Visser et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks Potential Mechanisms Beyond Nitric Oxide Synthase Inhibition
Zeneng Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Cellular ADMA: Regulation and action
Tom Teerlink et al.
PHARMACOLOGICAL RESEARCH (2009)
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
Wai Hong Wilson Tang et al.
EUROPEAN HEART JOURNAL (2008)
Reduced myocardial and systemic L-arginine uptake in heart failure
DM Kaye et al.
CIRCULATION RESEARCH (2002)
Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells
TA Hardy et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)